ライフサイエンスコーパス: HRCT

1 HRCT abnormalities, as well as their anatomical distribu

2 HRCT can distinguish between active inflammatory changes

3 HRCT demonstrated virtually no evidence of interstitial

4 HRCT is another modality which would be useful when the

5 HRCT is used as a problem-solving tool in patients with

6 HRCT revealed that 76% of autoantibody-positive subjects

7 HRCT scans were evaluated in a blinded manner for ground

8 HRCT scores correlated significantly with DL(CO), gas ex

9 HRCT sections involved 0.625 to 0.8-mm sections in the c

10 HRCT was scored for individual features and these featur

11 s--which were present on about 1 of every 12 HRCT scans--were associated with reduced total lung capa

12 alities were present in 194 (8%) of the 2416 HRCT scans evaluated.

13 tiple positive NTM cultures, but an abnormal HRCT was predictive of progression.

14 ntrol subjects, and correlated with abnormal HRCT scans.

15 There were no significant differences among HRCT diagnostic categories between IIP and CTD-ILD.

16 (95% confidence interval [CI], 1.7-9.2) and HRCT response by 4.9 times (95% CI, 1.9-13.0).

17 between interstitial lung abnormalities and HRCT measurements of total lung capacity and emphysema.

18 Combination of MR cisternography and HRCT appears to be complementary, accurate and non-invas

19 ve value [NPV] of both MR cisternography and HRCT together were 93%, 100%, 100% and 50% respectively.

20 In most subjects with typical clinical and HRCT features of idiopathic UIP, neither prednisone nor

21 Their clinical features and HRCT findings were investigated to predict the risk for

22 was seen between exacerbation frequency and HRCT changes.

23 We integrated prognostic physiological and HRCT variables to form a clinical staging algorithm pred

24 ed from sputum or gastric lavage, as well as HRCT were performed in all children prior to administrat

25 We assessed HRCT scans from patients with IPF (n = 315) enrolled in

26 At HRCT 40 out of 44 patients with class III ranking showed

27 nges; and 4) patients who exhibited atypical HRCT changes.

28 phosphamide [n=63]) with acceptable baseline HRCT studies and at least one outcome measure were inclu

29 everity of reticular infiltrates on baseline HRCT and the baseline MRSS as patient features that migh

30 The baseline HRCT fibrosis score is a predictor of a future decline i

31 ry and LCI in PCD and no correlation between HRCT features and LCI or spirometry in PCD.

32 14%) had evidence of interstitial changes by HRCT, whereas 35.2% had abnormalities on transbronchial

33 the mean airway lumenal area as measured by HRCT and the mean partial spirometric outcomes were high

34 ltiple positive NTM cultures, characteristic HRCT findings, and progression of HRCT changes should be

35 L), and 15 of these patients underwent chest HRCT.

36 graphy alone and combined CT cisternography, HRCT and MR cisternography, the results were not statist

37 The most common HRCT presentation of COP was ground-glass opacity (GGO)

38 variability of HRCT findings and correlated HRCT abnormalities with physiologic measures in 57 patie

39 We correlated HRCT with spirometry, body plethysmographic lung volumes

40 attenuation of thoracic high-resolution CT (HRCT) abnormalities and serum markers of lung fibrosis.

41 pulmonary function, and high-resolution CT (HRCT) criteria.

42 eoperative (</=3 months) high resolution CT (HRCT) was performed for 118 pulmonary nodules of the ade

43 Either a bone defect on high resolution CT [HRCT] or CSF column extending extracranially from the su

44 by 2.3 times (95% CI, 1.1-5.2) but decreased HRCT response by 4.4 times (95% CI, 1.7-11.5).

45 work is to study the usage of multi-detector HRCT chest in diagnosing pulmonary TB cases whose sputum

46 two or more characteristic findings on entry HRCT (60%, 9/15) as compared with subjects with two posi

47 dicted alveolitis in the middle lung fields, HRCT did not detect all sites of inflammation and did no

48 r longer) for culture, 60% (5.5-11.5 mo) for HRCT, and 53% (8.5 mo) for symptoms.

49 and LCI, of which a subset of 21 of each had HRCT performed.

50 as present in all of the 25 subjects who had HRCT.

51 male patients had crazy-paving on their lung HRCT (p=0.02).

52 hose smears are negative can benefit from MD HRCT chest findings to predict those patients of high ri

53 MATERIAL/METHODS: HRCT images of 35 patients (mean age: 38+/-14years; 54.3

54 MATERIAL/METHODS: HRCT scans of 31 sequential patients (mean age: 54.3+/-1

55 The main advantage of HRCT is a very detailed depiction of the lung parenchyma

56 initial interpretation and classification of HRCT findings.

57 A total of 25 patients had a combination of HRCT and MR cisternography.

58 initially focusing on the interpretation of HRCT findings may prove of considerable value provided t

59 acteristic HRCT findings, and progression of HRCT changes should be monitored closely and considered

60 and exit HRCTs (n = 6) showed progression of HRCT findings, whereas only 17% of subjects with two pos

61 o evaluate AMFM and visual quantification of HRCT patterns and their relationship with disease progre

62 Reliability of HRCT scan measurements were assessed using weighted kapp

63 To evaluate the role of HRCT in quantifying emphysema in severe COPD patients an

64 Material/Automatic lung segmentation of HRCT scans in 41 severe COPD patients (GOLD stage III or

65 ography (HRCT); however, the repeated use of HRCT is limited because of concerns regarding radiation

66 rrater reliability and construct validity of HRCT-reported nodules, ground-glass opacity, or other ty

67 terobserver and intraobserver variability of HRCT findings and correlated HRCT abnormalities with phy

68 possible UIP with traction bronchiectasis on HRCT and had not undergone surgical lung biopsy had dise

69 nce of moderate lower lobe bronchiectasis on HRCT is common in COPD and is associated with more sever

70 n of 54 patients (50%) had bronchiectasis on HRCT, most frequently in the lower lobes (18 of 54, 33.3

71 The main presentations of COP on HRCT include bilateral GGOs and consolidations in the lo

72 ponent of the disease, must be determined on HRCT, either qualitatively or quantitatively.

73 The correlation between fibrosis on HRCT and the presence of alveolitis on BAL was significa

74 When stratified by baseline fibrosis on HRCT, the rate of decline in the FVC% predicted was stat

75 h-risk patients without specific findings on HRCT scans, and it is most useful in the presence of wel

76 up analysis of patients with honeycombing on HRCT and/or confirmation of UIP by biopsy versus patient

77 ib, to that of patients with honeycombing on HRCT and/or confirmation of UIP by biopsy.

78 Extent of reticulation and honeycombing on HRCT is an important independent predictor of mortality

79 pathological findings could be identified on HRCT of the lungs and no respiratory symptoms were consi

80 one was involved by reticular infiltrates on HRCT and/or whether patients exhibited an MRSS of at lea

81 A study-site diagnosis of IPF on HRCT was regularly confirmed by core radiologists.

82 milarly, while ground-glass opacification on HRCT accurately predicted alveolitis in the middle lung

83 of fibrosis (QLF) and of total ILD (QILD) on HRCT.

84 Only HRCT imaging and pathologic fibrosis were able to reliab

85 MR cisternography, 5 patients underwent only HRCT and one patient underwent HRCT, MR cisternography a

86 e provided thorough familiarity with optimal HRCT techniques and methods of interpretation.

87 Other HRCT findings were: consolidation (63%), pulmonary nodul

88 The predominant HRCT pattern was decreased attenuation as part of a mosa

89 This study demonstrated that the predominant HRCT presentation of idiopathic PAP was interlobular sep

90 The predominant HRCT presentation of PAP was interlobular septal thicken

91 We then designed provisional HRCT diagnostic criteria based on the results to rank th

92 positive likelihood ratio of class I ranking HRCT criteria to diagnose active pulmonary TB were 95%,

93 Due to its excellent spatial resolution, HRCT is invaluable in assessment of chronically discharg

94 Due to its better spatial resolution, HRCT is preferred in suspected intra temporal complicati

95 A high-resolution CT scan (HRCT) was independently scored by four radiologists for

96 58% difference) in patients with less severe HRCT findings and a lower MRSS at baseline.

97 This study demonstrates that HRCT has good interrater reliability and correlates with

98 ange in FEV1 and exacerbations suggests that HRCT may be a more appropriate outcome surrogate for lon

99 We show for the first time that HRCT, spirometry, and LCI have different relationships i

100 The HRCT scans of chronic sarcoidosis patients tended to sho

101 Interobserver agreement for three of the HRCT abnormalities found in CBD was moderate: the K(W) f

102 On the HRCT images, airway area decreased in response to the in

103 objective and subjective density values, the HRCT-based visual density values are satisfactory.

104 We categorized these patients based on their HRCT results into four groups: 1) patients diagnosed wit

105 Even though HRCT findings are not always specific, there are several

106 ll thickening without emphysema according to HRCT than did asymptomatic current or former smokers.

107 These data suggest that, in addition to HRCT, BAL with lavage, differential cell counting, and c

108 on, or high-resolution computed tomographic (HRCT) scan of the chest.

109 ts had high-resolution computed tomographic (HRCT) scans indicating centrilobular nodules with adjoin

110 f 2508 high-resolution computed tomographic (HRCT) scans of the lung obtained from a cohort of smoker

111 a using high resolution computed tomography (HRCT) and airflow using partial spirometry in five norma

112 Both high resolution computed tomography (HRCT) and MRI are helpful in evaluating middle ear patho

113 is on a high-resolution computed tomography (HRCT) and the results of sputum smear.

114 res) on high-resolution computed tomography (HRCT) at baseline, the modified Rodnan skin thickness sc

115 sts and high resolution computed tomography (HRCT) diagnosis and scoring.

116 ine the high resolution computed tomography (HRCT) features of idiopathic PAP.

117 between high-resolution computed tomography (HRCT) findings in chronic obstructive pulmonary disease

118 ed from High Resolution Computed Tomography (HRCT) images of grapevine (Vitis vinifera cv. 'Chardonna

119 High-resolution computed tomography (HRCT) is an integral aspect of the evaluation of patient

120 lthough high resolution computed tomography (HRCT) is commonly used to assess interstitial lung disea

121 try and high-resolution computed tomography (HRCT) lung imaging.

122 , using high-resolution computed tomography (HRCT) of the chest and a separation of diffusing capacit

123 lity of high-resolution computed tomography (HRCT) of the chest, in comparison with bronchoalveolar l

124 EV1 and high-resolution computed tomography (HRCT) of the chest.

125 f chest high-resolution computed tomography (HRCT) often delay definitive diagnosis of these infectio

126 alue of high-resolution computed tomography (HRCT) patterns and pulmonary function tests, including t

127 ognizes high-resolution computed tomography (HRCT) patterns.

128 y high-resolution chest computed tomography (HRCT) scan, was determined in patients with TSC without

129 d high-resolution chest computed tomography (HRCT) scanning in an ongoing cohort study; 72 consented

130 ties in high-resolution computed tomography (HRCT) scanning.

131 ings on high resolution computed tomography (HRCT) scans in patients with COP.

132 ed upon high resolution computed tomography (HRCT) scans.

133 aphs or high-resolution computed tomography (HRCT) scans.

134 High-resolution computed tomography (HRCT) studies are now almost always obtained for patient

135 we used high-resolution computed tomography (HRCT) to examine the ability of a DI to distend the airw

136 osis on high-resolution computed tomography (HRCT) were performed, and interactions between disease s

137 ulture, high-resolution computed tomography (HRCT), and symptoms were assessed.

138 ea with high resolution computed tomography (HRCT).

139 IP), on high-resolution computed tomography (HRCT).

140 d using high-resolution computed tomography (HRCT).

141 y high-resolution chest computed tomography (HRCT); however, the repeated use of HRCT is limited beca

142 either high-resolution computed tomography (HRCT, n = 25) or open-lung biopsy (OLB, n = 1) patterns

143 O], and high-resolution computed tomography [HRCT] of the lungs) from a prospective 3.5-year observat

144 e staging system integrating the CPI and two HRCT variables.

145 c disease; 3) patients who exhibited typical HRCT changes; and 4) patients who exhibited atypical HRC

146 azathioprine, and N-acetylcysteine underwent HRCT at study start and finish.

147 nderwent only HRCT and one patient underwent HRCT, MR cisternography and CT cisternography.

148 g, 50.5 [33.5] smoking pack-years) underwent HRCT scans of the chest to quantify the presence and ext

149 We performed this study to validate HRCT, a proposed surrogate outcome measure for CF lung d

150 values on inspiration and expiration, visual HRCT scores, and pulmonary function tests were obtained.

151 c characteristic most highly correlated with HRCT findings.

152 Though PPV was 100% in the groups with HRCT alone, MR cisternography alone and combined CT cist